Heart Center, Turku University Hospital and Department of Surgery, University of Turku, Turku, Finland.
Research Unit of Surgery, Anesthesiology and Critical Care, University of Oulu, Oulu, Finland.
Infect Control Hosp Epidemiol. 2020 Apr;41(4):444-451. doi: 10.1017/ice.2019.375. Epub 2020 Jan 20.
To develop a risk score for deep sternal wound infection (DSWI) after isolated coronary artery bypass grafting (CABG).
Multicenter, prospective study.
Tertiary-care referral hospitals.
The study included 7,352 patients from the European multicenter coronary artery bypass grafting (E-CABG) registry.
Isolated CABG.
An additive risk score (the E-CABG DSWI score) was estimated from the derivation data set (66.7% of patients), and its performance was assessed in the validation data set (33.3% of patients).
DSWI occurred in 181 (2.5%) patients and increased 1-year mortality (adjusted hazard ratio, 4.275; 95% confidence interval [CI], 2.804-6.517). Female gender (odds ratio [OR], 1.804; 95% CI, 1.161-2.802), body mass index ≥30 kg/m2 (OR, 1.729; 95% CI, 1.166-2.562), glomerular filtration rate <45 mL/min/1.73 m2 (OR, 2.410; 95% CI, 1.413-4.111), diabetes (OR, 1.741; 95% CI, 1.178-2.573), pulmonary disease (OR, 1.935; 95% CI, 1.178-3.180), atrial fibrillation (OR, 1.854; 95% CI, 1.096-3.138), critical preoperative state (OR, 2.196; 95% CI, 1.209-3.891), and bilateral internal mammary artery grafting (OR, 2.088; 95% CI, 1.422-3.066) were predictors of DSWI (derivation data set). An additive risk score was calculated by assigning 1 point to each of these independent risk factors for DSWI. In the validation data set, the rate of DSWI increased along with the E-CABG DSWI scores (score of 0, 1.0%; score of 1, 1.8%; score of 2, 2.2%; score of 3, 6.9%; score ≥4: 12.1%; P < .0001). Net reclassification improvement, integrated discrimination improvement, and decision curve analysis showed that the E-CABG DSWI score performed better than other risk scores.
DSWI is associated with poor outcome after CABG, and its risk can be stratified using the E-CABG DSWI score.
clinicaltrials.gov identifier: NCT02319083.
为孤立性冠状动脉旁路移植术(CABG)后深部胸骨伤口感染(DSWI)开发风险评分。
多中心前瞻性研究。
三级保健转诊医院。
该研究纳入了来自欧洲多中心冠状动脉旁路移植术(E-CABG)注册中心的 7352 名患者。
孤立性 CABG。
从推导数据集(患者的 66.7%)中估算出一个附加风险评分(E-CABG DSWI 评分),并在验证数据集(患者的 33.3%)中评估其性能。
181 名(2.5%)患者发生 DSWI,1 年死亡率增加(调整后的危险比,4.275;95%置信区间[CI],2.804-6.517)。女性(比值比[OR],1.804;95%CI,1.161-2.802)、体重指数≥30kg/m2(OR,1.729;95%CI,1.166-2.562)、肾小球滤过率<45mL/min/1.73m2(OR,2.410;95%CI,1.413-4.111)、糖尿病(OR,1.741;95%CI,1.178-2.573)、肺部疾病(OR,1.935;95%CI,1.178-3.180)、心房颤动(OR,1.854;95%CI,1.096-3.138)、危急术前状态(OR,2.196;95%CI,1.209-3.891)和双侧内乳动脉移植(OR,2.088;95%CI,1.422-3.066)是 DSWI 的预测因素(推导数据集)。通过为每个这些独立的 DSWI 风险因素分配 1 分,计算了一个附加风险评分。在验证数据集中,DSWI 发生率随着 E-CABG DSWI 评分的增加而增加(评分 0:1.0%;评分 1:1.8%;评分 2:2.2%;评分 3:6.9%;评分≥4:12.1%;P<.0001)。净重新分类改善、综合判别改善和决策曲线分析表明,E-CABG DSWI 评分的表现优于其他风险评分。
DSWI 与 CABG 后不良预后相关,可使用 E-CABG DSWI 评分对其风险进行分层。
clinicaltrials.gov 标识符:NCT02319083。